Persistent B-cell depletion after ublituximab for multiple sclerosis. Gabelic T, Tesija K, Sredanovic M, Adamec I, et al. J Neurol 2026;273:536.

Read + Share

Amedeo Smart

Independent Medical Education

Gabelic T, Tesija K, Sredanovic M, Adamec I, et al. Persistent B-cell depletion after ublituximab for multiple sclerosis. J Neurol 2026;273:536.
PMID: 42627521